Omico is evolving tumour genomics into hard evidence for precision oncology

Omico’s development and growth in precision oncology, recently boosted by significant funding in the 2026-27 Budget, is also producing a substantial library of patient-level data that demonstrates that genomic profiling of tumours changes lives and could reshape how Australia funds and delivers cancer care. …